D. Bruennert

The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence

B. Brors, I. Bruns, Ron-Patrick Cadeddu, 2009, Leukemia.

High Prevalence of Intestinal Pathogens in Indigenous in Colombia

H. Frickmann, R. Hagen, D. Bruennert, 2020, Journal of clinical medicine.

Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study

R. Fenk, R. Haas, R. Kronenwett, 2008, Hematological oncology.

Computational and biochemical analyses reveal that cofilin-2 self assembles into amyloid-like structures and promotes the aggregation of other proteinaceous species: Pathogenic relevance to myopathies

K. Kar, P. Goyal, E. Hanschmann, 2021, bioRxiv.

Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network

T. Kohlmann, C. Denkert, E. Dahl, 2017, Gynecologic and Obstetric Investigation.

Polymorphism of the IL-8 gene and the risk of ovarian cancer.

J. Sehouli, M. Evert, M. Zygmunt, 2015, Cytokine.

Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy

I. Bruns, R. Haas, R. Kronenwett, 2009, Leukemia.